MUC16 c.42797C>A ;(p.A14266E)

Variant ID: 19-8971795-G-T

NM_024690.2(MUC16):c.42797C>A;(p.A14266E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics
Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H
Publication Date: 2021

Variant appearance in text: MUC16: 42797C>A; A14266E
PubMed Link: 34158843
Variant Present in the following documents:
  • thnov11p7175s3.xlsx, sheet 1
View BVdb publication page